Price Chart
Key Statistics
Market Cap(EOD)550.46M
Enterprise Value418.86M
P/E Ratio (TTM)-12.28
P/B Ratio (TTM)3.02
P/S Ratio (TTM)7.74
Earnings Yield (TTM)-8.14%
ROE (TTM)-163.62%
ROIC (TTM)-22.43%
Net Profit Margin (TTM)N/A
Dividend Yield (TTM)N/A
Payout Ratio (TTM)N/A
Debt/Equity (TTM)0.12
About CeriBell, Inc.
CeriBell, Inc. develops AI based point-of-care electroencephalography (EEG) technology for the detection and treatment of neurological conditions. The company develops Ceribell System, a novel, point-of-care EEG platform to address the unmet needs of patients in the acute care setting. It also offers EEG disposable headbands; and pocket-sized battery-operated recorders. The company was formerly known as Brain Stethoscope, Inc. and changed its name to CeriBell, Inc. in August 2015. The company was incorporated in 2014 and is based in Sunnyvale, California.